for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Renalytix PLC (ADR)

RNLX.OQ

Latest Trade

25.00USD

Change

0.58(+2.38%)

Volume

10,516

Today's Range

24.69

 - 

25.30

52 Week Range

10.41

 - 

35.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Renalytix Plc Appoints Ann Berman To Board Of Directors

July 28 (Reuters) - Renalytix PLC <RENX.L>::RENALYTIX PLC - APPOINTMENT OF ANN BERMAN TO BOARD OF DIRECTORS.

Renalytix Plc Announces Death Of Co-Founder Barbara Murphy

July 1 (Reuters) - Renalytix PLC <RENX.L>::RENALYTIX PLC - DIRECTORATE CHANGE.RENALYTIX PLC - ANNOUNCES DEATH OF BARBARA MURPHY, NON-EXECUTIVE DIRECTOR AND CO-FOUNDE.

Renalytix Ai Operating Expense For Qtr Was $8.1 Mln

June 15 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI - OPERATING EXPENSE FOR THREE MONTHS ENDED MARCH 31, 2021 WAS $8.1 MILLION COMPARED WITH $2.7 MILLION DURING THREE MONTHS ENDED MARCH 31, 2020.RENALYTIX AI PLC - RESEARCH AND DEVELOPMENT EXPENSES INCREASED BY $1.7 MILLION TO $3.1 MILLION FOR THREE MONTHS ENDED MARCH 31, 2021.

Renalytix AI, Atrium Health, Wake Forest Baptist Health, Wake Forest School Of Medicine Partner To Advance Kidney Health

May 19 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI PLC - PARTNERSHIP.RENALYTIX AI PLC - ATRIUM HEALTH, WAKE FOREST BAPTIST HEALTH, WAKE FOREST SCHOOL OF MEDICINE AND RENALYTIX PARTNER TO ADVANCE KIDNEY HEALTH.

Renalytix AI Plc Receives 10-Year US Government Contract Award

April 22 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI PLC - 10-YEAR US GOVERNMENT CONTRACT AWARD.RENALYTIX AI PLC - U.S. GENERAL SERVICES ADMINISTRATION GRANTS 10-YEAR GOVERNMENTWIDE CONTRACT FOR RENALYTIXAI KIDNEYINTELX TESTING.

Renalytix AI Says Positive Clinical Outcome Data For KidneyIntelX

April 20 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI PLC - POSITIVE CLINICAL OUTCOME DATA FOR KIDNEYINTELX.

Renalytix AI Plc Qtrly Net Loss Attributable $8.9 Mln

March 2 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI - NET LOSS ATTRIBUTABLE TO ORDINARY SHAREHOLDERS $8.9 MILLION FOR 3 MONTHS ENDED DEC 31, 2020, VERSUS $4.7 MILLION FOR 3 MONTHS ENDED DEC 31, 2019.

Renalytix AI Reports HY Net Pretax Loss Of $16.2 Mln

March 2 (Reuters) - Renalytix AI PLC <RENX.L>::H1 NET PRETAX LOSS -16.2 MILLION USD.

Renalytix AI Announces Partnership With Davita

Jan 5 (Reuters) - Renalytix AI PLC <RENX.L>::PARTNERSHIP BETWEEN RENALYTIXAI AND DAVITA.EARLY RISK IDENTIFICATION AT CORE OF INNOVATIVE KIDNEY CARE PARTNERSHIP BETWEEN RENALYTIXAI, DAVITA.

Renalytix AI Plc In Partnership With National Kidney Foundation

Dec 2 (Reuters) - Renalytix AI PLC <RENX.L>::RENALYTIX AI PLC - PARTNERSHIP WITH NATIONAL KIDNEY FOUNDATION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up